Jacob Beniflah
Designed by a pediatrician, BiliCalc uses the American Academy of Pediatrics 2004 "Management of Hyperbilirubinemia in Infants Greater than 35 Weeks of Age" to calculate the threshold for starting phototherapy based on the patient's age, bilirubin level, and neurotoxicity risk. Values are now displayed on the phototherapy nomogram. In addition, it will also tell you the patient's risk zone using the Bhutani Nomogram.
최근 관측된 다운로드 가격은 $1.99입니다. 현재 결제 가격은 공식 App Store 링크에서 확인하세요.
현재 선택한 스토어에서 관측된 다운로드 가격입니다. 지역별 가격에서 국가별 환산 가격을 비교할 수 있습니다.
Apple 공개 App Store 페이지에서 현재 확인되는 항목입니다. App Store Connect의 전체 상품 목록과 다를 수 있습니다.
출처: Apple 공개 App Store 페이지 · 공개 항목만 포함
Designed by a pediatrician, BiliCalc uses the American Academy of Pediatrics 2004 "Management of Hyperbilirubinemia in Infants Greater than 35 Weeks of Age" to calculate the threshold for starting phototherapy based on the patient's age, bilirubin level, and neurotoxicity risk. Values are now displayed on the phototherapy nomogram. In addition, it will also tell you the patient's risk zone using the Bhutani Nomogram.
Allows direct age input and includes the option to calculate age from birth and lab sample times. The app has a direct link to source journal articles, nomograms, and a list of the neurotoxicity risk factors. Supports US and SI units (mg/dL and µmol/L).
App Feature Summary
-Calculates phototherapy threshold for newborns 35 weeks and older
-Displays values on phototherapy nomogram
-Suggests time frame for followup bilirubin levels based on patient risk zone
-Direct links to reference journal articles
**********************************
Frequently Asked Questions
**********************************
1. I think the graph is backwards. Why is low risk on top and high risk on bottom?
The graph is directly from the 2004 AAP Hyperbilirubinemia Guidelines. The degree of "risk" refers to the infant's risk for developing neurotoxicity. This is different than the Bhutani Nomogram in which "risk" refers to the risk for development of severe hyperbilirubinemia. The threshold for treatment (when a data point lies above one of the lines on the graph) of the infant is different based on the predisposing factors (divided into the three risk categories). Babies who are "low neurotoxicity risk," can tolerate higher levels of bilirubin than a baby with medium or high risk. Therefore, a high risk baby will be treated at lower bilirubin levels than a low risk baby. The graph is correct in having low risk on top since a higher value is needed to pass the threshold for treatment (phototherapy). Please see the graph here for verification as well: http://bit.ly/AppPWU. Please email if you have further questions.
******************************************
Intended for use by pediatricians, neonatologists, physicians, medical students, and pediatric nurses who treat newborn infants in the hospital and as outpatients.
BiliCalc should be used only as a reference aid. The information contained in the app should not be used as a substitute for the exercise of professional clinical judgement. Please contact the developer if you find any errors.
Keywords: bilitool, bilitool.org, jaundice, hyperbiliubinemia
최근 관측된 App Store 데이터를 바탕으로 한 빠른 답변입니다.
최근 관측된 다운로드 가격은 $1.99입니다. 현재 결제 가격은 공식 App Store 링크에서 확인하세요.
Apple 공개 페이지에는 현재 이 스토어에서 0개의 구매 항목이 표시됩니다. 공개 목록은 완전하지 않을 수 있습니다.
네. App Store 가격은 스토어, 통화, 세금 및 개발자 가격 설정에 따라 달라질 수 있습니다. 현재 6개 지역의 관측 데이터가 있습니다.